26Jul 2023
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

The study suggested targeting and modifying the microbiota could overcome treatment resistance and enhance patient safety. The mechanisms behind the microbiota's impact on antitumour immunity still need exploration. Understanding this link and identifying a 'healthy' microbiota could revolutionize cancer care. Diet and gut microbiota's role in shaping immune responses during immune-checkpoint inhibitor treatment are also explored.

  • #oncology

Like

Save

Share